Assessment of endothelial function as a marker of cardiovascular risk in patients with rheumatoid arthritis

International Journal of Rheumatic Diseases

Volumn 13, Issue 3, 2010, Pages 189-195

  Khan, Faisel ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Cardiovascular risk; Endothelium; Non invasive assessment; Rheumatoid arthritis

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; THROMBOMODULIN;

ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; DOPPLER FLOWMETRY; ENDOTHELIAL DYSFUNCTION; EPITHELIUM CELL; FIBRINOLYSIS; HUMAN; NON INVASIVE PROCEDURE; PHOTOELECTRIC PLETHYSMOGRAPHY; PRIORITY JOURNAL; PROTECTION; REVIEW; RHEUMATOID ARTHRITIS; STEM CELL; THROMBOCYTE AGGREGATION INHIBITION; TONOMETRY; VASCULAR ENDOTHELIUM; VASODILATATION;

ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; ENDOTHELIUM, VASCULAR; HUMANS; HYPEREMIA; LASER-DOPPLER FLOWMETRY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; VASODILATION; VASODILATOR AGENTS;

EID: 77955380366     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2010.01480.x     Document Type: Review

References (61)

1. Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdalile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 2008, 59:1690-7.
2. Celermajer DS, Sorensen KE, Gooch VM. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992, 340(8828):1111-15.
3. Khan F, Green FC, Forsyth JS, Greene SA, Morris AD, Belch JJF. Impaired microvascular function in normal children: effects of adiposity and poor glucose handling. J Physiol 2003, 551(Pt 2):705-11.
4. Gonzalez MA, Selwyn AP. Endothelial function, inflammation, and prognosis in cardiovascular disease. Am J Med 2003, 115:99S-106S.
5. Napoli C, Ignarro LJ. Nitric oxide and atherosclerosis. Nitric Oxide 2001, 5(2):88-97.
6. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999, 340:115-26.
7. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342:836-43.
8. Ludmer PL, Selwyn AP, Shook TL. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986, 315(17):1046-51.
9. Khan F, Coffman JD. Enhanced cholinergic vasodilation in the skin of patients with Raynaud's phenomenon. Circulation 1994, 89:1183-8.
10. Anderson TJ, Uehata A, Gerhard MD. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995, 26(5):1235-41.
11. Joannides R, Haefeli WE, Linder L. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995, 91:1314-19.
12. Shechter M, Issachar A, Marai I. Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease. Int J Cardiol 2009, 134:52-8.
13. Gokce N, Keaney JF, Hunter LM. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol 2003, 41(10):1769-75.
14. Akcakoyun M, Kargin R, Tanalp AC. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events and restenosis in patients undergoing coronary stent implantation: a prospective study. Coron Artery Dis 2008, 19(5):337-43.
15. Karatzis EN, Ikonomidis I, Vamvakou GD. Long-term prognostic role of flow-mediated dilatation of the brachial artery after acute coronary syndromes without ST elevation. Am J Cardiol 2006, 98:1424-8.
16. Staniloae C, Mandadi V, Kurian D. Pioglitazone improves endothelial function in non-diabetic patients with coronary artery disease. Cardiology 2007, 108:164-9.
17. Kiliszek M, Maczewski M, Styczynski G, Duda M, Opolski G, Beresewicz A. Low-density lipoprotein reduction by simvastatin is accompanied by angiotensin II type 1 receptor downregulation, reduced oxidative stress, and improved endothelial function in patients with stable coronary artery disease. Coron Artery Dis 2007, 18:201-9.
18. Charbonneau F, Anderson TJ, Title L. Modulation of arterial reactivity using amlodipine and atorvastatin measured by ultrasound examination (MARGAUX). Atherosclerosis 2008, 197:420-7.
19. Faulx MD, Wright AT, Hoit BD. Detection of endothelial dysfunction with brachial artery ultrasound. Am Heart J 2003, 145:943-51.
20. Hannawi S, Marwick TH, Thoma R. Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis. Arthritis Res Ther 2009, 11:R51. http://dx.doi.org/1186/ar2668, http://arthritis-research.com/content/11/2/R51, (doi:).
21. Vaudo G, Marchesi S, Gerli R. Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis 2004, 63:31-5.
22. Hansel S, Lassig G, Pistrosch F, Passauer J. Endothelial dysfunction in young patients with long-term rheumatoid arthritis and low disease activity. Atherosclerosis 2003, 170:177-80.
23. Kerekes G, Szekanecz Z, Der H. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. J Rheumatol 2008, 35:398-406.
24. Rojas-Villarraga A, Ortega-Hernandez OD, Gomez LF. Risk factors associated with different stages of atherosclerosis in Colombian patients with rheumatoid arthritis. Semin Arthritis Rheum 2008, 38:71-82.
25. Flammer AJ, Sudano I, Hermann F. Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis. Circulation 2008, 117:2262-9.
26. Syngle A, Vohra K, Kaur L, Sharma S. Effects of spironolactone on endothelial dysfunction in rheumatoid arthritis. Scand J Rheumatol 2009, 38:15-22.
27. Mäki-Petäjä KM, Booth AD, Hall FC. Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis. J Am Coll Cardiol 2007, 50:852-8.
28. Gonzalez-Juanatey C, Testa A, Garcia-Castelo A, Garcia-Porrua C, Llorca J, Gonzalez-Gay MA. Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody. Arthritis Rheum 2004, 51:447-50.
29. Bosello S, Santoliquido A, Zoli A. TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis. Clin Rheumatol 2008, 27:833-9.
30. Sidiropoulos PI, Siakka P, Pagonidis K. Sustained improvement of vascular endothelial function during anti-TNFα treatment in rheumatoid arthritis patients. Scand J Rheumatol 2009, 38:6-10.
31. Morris SJ, Shore AC. Skin blood flow responses to the iontophoresis of acetylcholine and sodium nitroprusside in man: possible mechanisms. J Physiol 1996, 496:531-42.
32. Turner J, Belch JJF, Khan F. Current concepts in assessment of microvascular function using laser Doppler imaging and iontophoresis. Trends Cardiovasc Med 2008, 18:109-16.
33. Khan F, Mires G, McLeod M, Belch JJF. Changes in endothelial function precede the clinical disease in women who develop pre-eclampsia. Hypertension 2005, 46:1123-8.
34. Arosio E, De Marchi S, Rigoni A, Prior M, Delva P, Lechi A. Forearm haemodynamics, arterial stiffness and microcirculatory reactivity in rheumatoid arthritis. J Hypertens 2007, 25:1273-8.
35. Morris SJ, Shore AC, Tooke JE. Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDM. Diabetologia 1995, 38:1337-44.
36. Newton DJ, Khan F, Belch JJF. Assessment of microvascular endothelial function in human skin. Clin Sci 2001, 101:567-72.
37. Khan F, Patterson D, Belch JJF, Hirata K, Lang CC. Relationship between peripheral and coronary function using laser Doppler imaging and transthoracic echocardiography. Clin Sci 2006, 115:295-300.
38. Khan F, Elhadd TA, Greene SA, Belch JJF. Impaired skin microvascular function in children, adolescents, and young adults with type 1 diabetes. Diabetes Care 2000, 23:215-20.
39. Farkas K, Kolossvary E, Jarai Z, Nemcsik J, Farsang C. Non-invasive assessment of microvascular endothelial function by laser Doppler flowmetry in patients with essential hypertension. Atherosclerosis 2004, 173:97-102.
40. Khan F, Belch JJF. Skin blood flow in patients with systemic sclerosis and Raynaud's phenomenon: effects of oral L-arginine supplementation. J Rheumatol 1999, 26:2389-94.
41. Izjerman RG, de Jongh RT, Beijk MA. Individuals at increased coronary heart disease risk are characterized by an impaired microvascular function in skin. Eur J Clin Invest 2003, 33:536-42.
42. Khan F, Litchfield SJ, Stonebridge PA, Belch JJF. Lipid-lowering and skin vascular responses in patients with hypercholesterolemia and peripheral arterial obstructive disease. Vasc Med 1999, 4:233-8.
43. Franklin VL, Khan F, Kennedy G, Belch JJF, Greene SA. Intensive Insulin therapy improves endothelial function and microvascular reactivity in young people with Type 1 Diabetes. Diabetologia 2008, 51:353-60.
44. Kruger A, Stewart J, Sahityani R. Laser Doppler flowmetry detection of endothelial dysfunction in end-stage renal disease patients: correlation with cardiovascular risk. Kidney Int 2006, 70:157-64.
45. Cracowski JL, Minson CT, Salvat-Melis M, Halliwill R. Methodological issues in the assessment of skin microvascular endothelial function in humans. Trends Pharmacol Sci 2006, 27:503-8.
46. Datta D, Ferrell WR, Sturrock RD, Jadhav ST, Sattar N. Inflammatory suppression rapidly attenuates microvascular dysfunction in rheumatoid arthritis. Atherosclerosis 2007, 192:391-5.
47. Galarraga B, Khan F, Kumar P, Pullar T, Belch JJF. C-reactive protein: the underlying cause of microvascular dysfunction in rheumatoid arthritis. Rheumatology 2008, 47:1780-4.
48. Galarraga B, Belch JJF, Pullar T, Ogston S, Khan F. Clinical improvement in rheumatoid arthritis is associated with healthier microvascular function in patients who respond to antirheumatic therapy. J Rheumatol 2010, 37:521-8.
49. Wilkinson IB, Hall IR, MacCallum H. Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol 2002, 22:147-52.
50. Chowienczyk PJ, Kelly RP, MacCallum H. Photoplethysmographic assessment of pulse wave reflection: blunted response to endothelium-dependent beta2-adrenergic vasodilation in type II diabetes mellitus. J Am Coll Cardiol 1999, 34:2007-14.
51. Celemajer DS. Reliable endothelial function testing at our fingertips? Circulation 2008, 117:2428-30.
52. Avouac J, Uzan G, Kahan A, Boileau C, Allanore Y. Endothelial progenitor cells and rheumatic disorders. Joint Bone Spine 2008, 75:131-7.
53. Ablin JN, Boguslavski V, Aloush V. Effect of anti-TNFalpha treatment on circulating endothelial progenitor cells (EPCs) in rheumatoid arthritis. Life Sci 2006, 79:2364-9.
54. Belch JJ, Shaw JW, Kirk G. The white blood cell adhesion molecule E-selectin predicts restenosis in patients with intermittent claudication undergoing percutaneous transluminal angioplasty. Circulation 1997, 95:2027-31.
55. Elhadd TA, Kennedy G, Robb R, McLaren M, Jung RT, Belch JJF. Elevated soluble cell adhesion molecules E-selectin and intercellular cell adhesion molecule-1 in type-2 diabetic patients with and without asymptomatic peripheral arterial disease. Int Angiol 2004, 23:128-33.
56. Hope SA, Meredith IT. Cellular adhesion molecules and cardiovascular disease. Part II. Their association with conventional and emerging risk factors, acute coronary events and cardiovascular risk prediction. Intern Med J 2003, 33:450-62.
57. Klimiuk PA, Fiedorczyk M, Sierakowski S, Chwiecko J. Soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) in patients with early rheumatoid arthritis. Scand J Rheumatol 2007, 36:345-50.
58. Cobankara V, Ozatli D, Kiraz S. Successful treatment of rheumatoid arthritis is associated with a reduction in serum sE-selectin and thrombomodulin level. Clin Rheumatol 2004, 23:430-4.
59. Bernardo A, Ball C, Nolasco L, Moake JF, Dong JF. Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow. Blood 2004, 104:100-6.
60. McEntegart A, Capell HA, Creran D, Rumley A, Woodward M, Lowe GD. Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology 2001, 40:640-4.
61. Wallberg-Jonsson S, Cederfelt M, Rantapaa Dahlqvist S. Hemostatic factors and cardiovascular disease in active rheumatoid arthritis: an 8 year followup study. J Rheumatol 2000, 27:71-5.